Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Dibirdik I et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
Noda Y et al. | 2000 | isolated bio./chem. substance, supernatant of brain homogenates | magnetic field, static magnetic field, signals/pulses, 50/60 Hz | 0.1–20 mT |
Woods M et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 46–100 µT |
Singh S et al. | 1999 | animal, mouse/Swiss albino, whole body | magnetic field, 50/60 Hz | 2–10 mT |
Mevissen M et al. | 1999 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 100 µT |
Cress LW et al. | 1999 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 10 µT |
Mullins JM et al. | 1999 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz | 1–20 µT |
Kubinyi G et al. | 1998 | animal, mouse/CFLP (embryos and adults), whole body | magnetic field, 50/60 Hz | 100 µT |
Dibirdik I et al. | 1998 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) (wild-type, LYN-deficient, SYK-deficient, PLC-gamma2-deficient clones) | magnetic field, 50/60 Hz | 100 µT |
Katsir G et al. | 1998 | intact cell/cell culture, primary chick embryo fibroblasts | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.06–0.7 mT |
Blank M et al. | 1998 | isolated bio./chem. substance, organelle/cell part, mitochondria containing the cytochrome oxidase (enzyme) and cytochrome C (substrate) | magnetic field, 50/60 Hz | 10 µT |
Tuinstra R et al. | 1998 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz, co-exposure | 1.1 mT |
Kang KI et al. | 1998 | intact cell/cell culture, 34i cell line (derived from C3H mouse mammary epithelial carcinoma cells) | magnetic field, 50/60 Hz | 300–3,000 µT |
Kristupaitis D et al. | 1998 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) (wild-type, LYN-deficient, SYK-deficient, PLC-gamma2-deficient clones) | magnetic field, 50/60 Hz, co-exposure | 0.1 mT |
Litovitz TA et al. | 1997 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz | 10 µT |
Farrell JM et al. | 1997 | animal, chicken embryos (eggs), whole body | magnetic field, 50/60 Hz | 4 µT |
Mullins JM et al. | 1997 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz | 2.5–10 µT |
Valtersson U et al. | 1997 | intact cell/cell culture, CEM-CM3 (human acute lymphoblastic leukemia) cells and Jurkat cells (human lymphoblastoid T cells) | magnetic field, 50/60 Hz | 100 µT |
Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
Uckun FM et al. | 1995 | intact cell/cell culture, NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz | 100 µT |
Galt S et al. | 1995 | intact cell/cell culture, human amniotic cells | magnetic field, 50/60 Hz | 30 µT |
Azadniv M et al. | 1995 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz | 10 µT |
Martin AH et al. | 1995 | animal, chicken embryos/White Leghorn, whole body | magnetic field, 50/60 Hz | 4 µT |
Del Carratore R et al. | 1995 | animal, mouse/Swiss albino and rat/Wistar, whole body | magnetic field, 50/60 Hz, co-exposure | 1.2 mT |
Ohtsu S et al. | 1995 | intact cell/cell culture, PC-12 cells | magnetic field, 50/60 Hz | 200–400 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.